Domatinostat Targets the FOXM1–Survivin Axis to Reduce the Viability of Ovarian Cancer Cells Alone and in Combination with Chemotherapeutic Agents
Article in International Journal of Molecular Sciences (June 2023)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in International Journal of Molecular Sciences (June 2023)
Article in Journal of Gynecologic Oncology (September 2022)
Article in International Journal of Molecular Sciences (June 2022)